Sep 20 |
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
|
Sep 16 |
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
|
Sep 16 |
Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024
|
Sep 5 |
Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 21 |
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth
|
Aug 14 |
Unicycive Therapeutics GAAP EPS of -$0.29
|
Aug 14 |
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
|
Jul 17 |
Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
|
Jul 11 |
Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
|
Jul 10 |
Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)
|